Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Phenylephrine HCl prices in Germany, the highest-cost reporting region, edged up 1.2% in Q2 2026 to USD 174,000.00/MT from USD 172,000.00/MT in Q1, a modest stabilization after a gradual multi-quarter decline. US prices, which had held in the USD 155,000.00 to 175,000.00/MT range through most of 2025, rose 1.2% to USD 162,000.00/MT, also stabilizing after easing from USD 170,000.00/MT in Q3 2025 to USD 160,000.00/MT by Q1 2026. Globally, the average rose from USD 150,560.00/MT in Q1 to USD 152,560.00/MT in Q2, a 1.3% gain, the first quarterly increase after five consecutive quarters of gradual decline. For H2 2026, a global average of USD 128,000.00-180,000.00/MT is expected, with steady OTC decongestant demand likely to keep this market broadly stable.
Phenylephrine HCl is a synthetic sympathomimetic amine active pharmaceutical ingredient used as the hydrochloride salt in over-the-counter and prescription decongestant medications, formulated into tablets, nasal sprays, and injectable solutions for both cold and allergy relief and clinical blood pressure management. Global market demand continues expanding, underpinned by rising demand for decongestant medications, growing OTC pharmaceutical consumption, and the phase-out of pseudoephedrine-based alternatives in several regulated markets due to controlled-substance restrictions on pseudoephedrine precursor chemicals. North America remains the dominant regional market, driven by high-volume OTC cold and allergy medication sales and robust pharmaceutical distribution infrastructure. Key synthesis intermediate costs, OTC decongestant and pharmaceutical demand, and regional import availability are what drive prices in this market.
The outlook for Phenylephrine HCl through H2 2026 stays broadly stable, tracking a balance between rising raw material input costs and increasing import availability from Asia. Rising demand for decongestant medications, growing OTC pharmaceutical consumption, and continued phase-out of pseudoephedrine-based alternatives in regulated markets should continue supporting the underlying demand base even as pricing remains sensitive to regional oversupply conditions.
The main upside risk is a further acceleration of pseudoephedrine phase-out policies in regulated markets, which could sharply increase demand for this alternative decongestant API. The main downside risk is a continuation of the oversupply conditions in the broader Asia Pacific API market that pressured pricing through most of 2025, which could extend the gradual decline further.
| Region | 2026 Price Range (USD/MT) | Outlook |
| Global Average | 128,000.00 - 180,000.00 | Steady OTC decongestant demand keeps this market broadly stable |
| Germany | 168,000.00 - 190,000.00 | Established European formulator base sustains the highest cost |
| United States | 155,000.00 - 175,000.00 | Dominant OTC market position supports continued firmness |
| India | 132,000.00 - 152,000.00 | Growing generic API production keeps this market steady |
| China | 124,000.00 - 145,000.00 | Oversupply conditions keep this the most affordable market |
German Phenylephrine HCl prices averaged USD 174,000.00/MT in Q2 2026, the highest of any region tracked here, up 1.2% from USD 172,000.00/MT in Q1, a modest stabilization after a gradual multi-quarter decline.
Why did the price of Phenylephrine HCl change in Q2 2026 in Germany?
Steady demand from established European formulators, tied to both OTC and prescription decongestant medication production, kept this market at the top of the range tracked in this report.
US prices averaged USD 162,000.00/MT in Q2 2026, up 1.2% from USD 160,000.00/MT in Q1, holding within the broadly stable range that has characterized this market's dominant OTC position.
Why did the price of Phenylephrine HCl change in Q2 2026 in the United States?
Increasing import availability from Asia continued tempering cost pressures even as North America's dominant OTC cold and allergy medication market kept underlying demand robust.
Indian prices averaged USD 138,000.00/MT in Q2 2026, up 1.5% from USD 136,000.00/MT in Q1, as growing generic API production continued keeping this market steady.
Why did the price of Phenylephrine HCl change in Q2 2026 in India?
Continued growth in domestic generic API production capacity kept Indian buyers competing for available synthesis intermediates, supporting a modest stabilization through the quarter.
Chinese prices, the lowest of the four regions, averaged USD 130,000.00/MT in Q2 2026, up 1.6% from USD 128,000.00/MT in Q1, stabilizing after the sharper declines that had characterized this market through most of 2025.
Why did the price of Phenylephrine HCl change in Q2 2026 in China?
Oversupply conditions in the broader Asia Pacific API market continued easing modestly, allowing Chinese pricing to stabilize after the sharper declines recorded earlier in the year.
German prices fell 3.4% in Q1 2026 to USD 172,000.00/MT from USD 178,000.00/MT in Q4 2025, continuing the gradual multi-quarter decline.
Why did the price of Phenylephrine HCl change in Q1 2026 in Germany?
Global phenylephrine HCl API prices maintained broadly stable to slightly pressured conditions, reflecting a balance between rising raw material input costs and increasing import availability from Asia, with German pricing continuing its gradual multi-quarter softening within that broader context.
US prices fell 3.0% in Q1 2026 to USD 160,000.00/MT from USD 165,000.00/MT in Q4 2025, easing to the lower end of the broadly stable 2025 range.
Why did the price of Phenylephrine HCl change in Q1 2026 in the United States?
North American prices eased from a Q3 2025 level near USD 170,000.00/MT toward USD 160,000.00/MT by Q1 2026, with the Phenylephrine Hydrochloride Price Index remaining broadly stable as increasing imports tempered cost pressures throughout the period.
Indian prices fell 2.9% in Q1 2026 to USD 136,000.00/MT from USD 140,000.00/MT in Q4 2025, continuing the gradual softening trend.
Why did the price of Phenylephrine HCl change in Q1 2026 in India?
Rising demand for decongestant medications and growing OTC pharmaceutical consumption provided underlying support even as increasing import availability from Asia continued tempering price gains across the broader market.
Chinese prices fell 3.8% in Q1 2026 to USD 128,000.00/MT from USD 133,000.00/MT in Q4 2025, extending the decline tied to declining producer prices and oversupply conditions.
Why did the price of Phenylephrine HCl change in Q1 2026 in China?
China posted a quarter-on-quarter decline in the phenylephrine HCl price index, driven by declining producer prices with manufacturing input costs falling, contributing to oversupply conditions in the broader Asia Pacific API market.
Global Phenylephrine HCl prices held broadly stable to slightly pressured through 2025, reflecting a balance between rising raw material input costs and increasing import availability from Asia, with China posting a notable oversupply-driven decline through the year, before prices across every region began stabilizing modestly heading into Q2 2026.
| Quarter | Price (USD/MT) | QoQ Change | Direction |
| Q2 2026 | 152,560.00 | +1.3% | ↑ Rising |
| Q1 2026 | 150,560.00 | -3.2% | ↓ Falling |
| Q4 2025 | 155,600.00 | -2.9% | ↓ Falling |
| Q3 2025 | 160,320.00 | -1.5% | ↓ Falling |
| Q2 2025 | 162,740.00 | - | — Stable |
| Q3 2026 | In Progress | - | — In Progress |
Phenylephrine HCl declined gradually across every market covered in this report through 2025, reflecting broadly stable to slightly pressured conditions as rising raw material input costs were offset by increasing import availability from Asia, with China posting the steepest annual decline of the four regions on oversupply conditions in the broader Asia Pacific API market.
German prices declined from about USD 185,000.00/MT in Q1 2025 to USD 178,000.00/MT by Q4, down roughly 3.8%, the smallest annual decline of the four regions.
US prices declined from about USD 172,000.00/MT in Q1 2025 to USD 165,000.00/MT by Q4, down roughly 4.1%, holding within the broadly stable USD 155,000.00 to 175,000.00 per metric ton range recorded throughout the year.
Indian prices declined from about USD 150,000.00/MT in Q1 2025 to USD 140,000.00/MT by Q4, down roughly 6.7%, tracking the broader Asian oversupply trend.
Chinese prices declined from about USD 145,000.00/MT in Q1 2025 to USD 133,000.00/MT by Q4, down roughly 8.3%, the steepest annual decline of the four regions, driven by declining producer prices and oversupply conditions.
Expert Market Research: Your Source for Real-Time Phenylephrine HCl Price Intelligence
Expert Market Research tracks Phenylephrine HCl prices continuously across every major producing and consuming region, combining key synthesis intermediate cost data, OTC decongestant and pharmaceutical demand signals, and regional import availability trends into a single, regularly updated view of the market. Our team can help your procurement function benchmark current offers, plan purchases around the trends covered in this report, and build a defensible view of where this essential decongestant API is headed next. Reach out to our team for a tailored briefing or a deeper look at any of the regional markets covered here.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It is used as the hydrochloride salt in over-the-counter and prescription decongestant medications, formulated into tablets, nasal sprays, and injectable solutions for both cold and allergy relief and clinical blood pressure management.
The Q2 2026 global average was USD 152,560.00/MT, ranging from USD 130,000.00/MT in China to USD 174,000.00/MT in Germany.
The global average fell from USD 155,600.00/MT in Q4 2025 to USD 150,560.00/MT in Q1 2026 before rising to USD 152,560.00/MT in Q2, the first quarterly increase after five consecutive quarters of gradual decline.
Rising demand for decongestant medications, growing OTC pharmaceutical consumption, and the phase-out of pseudoephedrine-based alternatives in several regulated markets due to controlled-substance restrictions have expanded the underlying demand base even as increasing import availability from Asia has tempered pricing.
The global average is expected in the USD 128,000.00-180,000.00/MT range, with steady OTC decongestant demand likely to keep this market broadly stable.
China holds the lowest cost among the regions tracked here given oversupply conditions, while Germany carries the highest cost given its established European formulator base.
This report is updated monthly. For real-time pricing intelligence, connect with the Expert Market Research team.
Key synthesis intermediate costs, OTC decongestant and pharmaceutical demand, and regional import availability.
China and India maintain substantial generic API production capacity, with North America remaining the dominant regional demand market given its high-volume OTC cold and allergy medication sales.
Buyers can monitor Asian oversupply conditions and regional import availability trends given their outsized influence on this market, time forward purchases around the quarterly breakdowns in this report, and benchmark supplier quotes against the tracked price ranges.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.